Europe Newborn Screening Market Forecast to 2030 - Regional Analysis - by Product Type (Reagents and Assay Kits, and Instruments), Technology, Test Type, and End User (Hospitals and Clinics, and Diagnostic Laboratories)

List of Tables

The Europe newborn screening market was valued at US$ 328.04 million in 2022 and is expected to reach US$ 653.83 million by 2030; it is estimated to grow at a CAGR of 9.0% from 2022 to 2030.

Rising Burden of Congenital Diseases Fuels the Europe Newborn Screening Market.

Congenital diseases can lead to lifelong health challenges if not detected and managed early. These diseases can contribute to long-term disability, significantly affecting families, individuals, healthcare systems, and societies. The WHO estimates that 240,000 newborns worldwide succumb to death each year within 28 days of birth due to these diseases. An additional 170,000 children die between the age of 1 month and 5 years due to congenital diseases. A growing understanding of the genetic basis of many congenital diseases is one of the several factors contributing to the increasing burden of these conditions. Advancements in genomics and genetic testing have enabled healthcare providers to identify a broader range of genetic mutations and conditions in newborns. This expanded knowledge has highlighted the importance of early diagnosis through newborn screening to initiate timely interventions and treatments.

Changing demographics such as maternal age, environmental exposures, and altering lifestyle habits increase the risk of congenital conditions in newborns. Moreover, the number of births occurring every day is on the rise due to the burgeoning global population, resulting in an expanding pool of infants that can be at risk of congenital diseases. In addition, healthcare systems and policymakers recognize the long-term benefits of early disease detection. They increasingly incorporate newborn screening into routine healthcare protocols and insurance coverage, further stimulating market growth. The rising burden of congenital diseases is a significant driver behind the growth of the newborn screening market.

Europe Newborn Screening Market Overview

The European newborn screening market is segmented into Germany, the UK, France, Italy, Spain , and the Rest of Europe. Growth of the newborn screening market in Europe is driven by increased healthcare spending and an upsurge in the occurrence of congenital diseases, neonatal diseases, and other newborn diseases. Developments in techniques employed in medical research and several diagnostic screening procedures for the early detection of illnesses are also benefiting the market in Europe. The number of newborn screening programs across the region is expected to increase rapidly as government and nongovernment organizations are developing measures to enhance mother-childcare. According to information by NCBI in 2022, screening is anticipated to benefit ~4,000 children annually in the EU. The development of innovative diagnostic methods (such as MS/MS and molecular technologies), therapeutic options (such as gene therapy and enzyme replacement therapies), and increased understanding of rare diseases are driving the expansion of newborn screening programs.

Healthcare providers in European countries are offering comprehensive newborn screening panels, encompassing a broader spectrum of genetic and metabolic conditions. Healthcare authorities in several European countries have implemented mandatory newborn screening programs, ensuring every newborn undergoes essential screenings shortly after birth. As per a data published by NCBI in 2023, both spinal muscular atrophy and severe combined immunodeficiency (SCID) screening are evolving quickly; Norway, Germany, and other European countries had plans to include SMA screening in their national screening programs from 2021 and 2022 onward. Regional pilot programs are already underway in many other nations. SCID screening was just launched in the Czech Republic. This legislative support has increased the overall volume of screening tests and created a stable and predictable market for screening service providers.

Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Million)

Europe Newborn Screening Market Segmentation

The Europe newborn screening market is segmented based on product type, technology, test type, end user, and country.

Based on product type, the Europe newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held a larger Europe newborn screening market share in 2022. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.

In terms of technology, the Europe newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held the largest Europe newborn screening market share in 2022.

Based on test type, the Europe newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held the largest Europe newborn screening market share in 2022.

By end user, the Europe newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held a larger Europe newborn screening market share in 2022.

By country, the Europe newborn screening market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. France dominated the Europe newborn screening market in 2022.

Bio-Rad Laboratories Inc, Masimo Corp, Medtronic Plc, MRC Holland BV, Natus Medical Inc, PerkinElmer Inc, Waters Corp, and Zentech SA are some of the leading companies operating in the Europe newborn screening market.

Product Code: BMIRE00029604

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Newborn Screening Market - Key Industry Dynamics

4.1 Key Market Drivers
- 4.1.1 Surging Government Funding for Newborn Screening
- 4.1.2 Rising Burden of Congenital Diseases
- 4.1.3 Increasing Prevalence of Newborn Disorders
4.2 Key Market Restraints
- 4.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
4.3 Key Market Opportunities
- 4.3.1 Genetic Screening of Newborns
4.4 Future Trends
- 4.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
4.5 Impact Analysis:

5. Newborn Screening Market - Europe Market Analysis

5.1 Europe Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

6. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

6.1 Overview
6.2 Europe Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
6.3 Reagents and Assay Kits
- 6.3.1 Overview
- 6.3.2 Reagents and Assay Kits: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.1 Europe Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
6.4 Instruments
- 6.4.1 Overview
- 6.4.2 Instruments: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.4.2.1 Europe Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

7. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

7.1 Overview
7.2 Europe Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
7.3 Tandem Mass Spectrometry (TMS)
- 7.3.1 Overview
- 7.3.2 Tandem Mass Spectrometry (TMS): Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Molecular Assays
- 7.4.1 Overview
- 7.4.2 Molecular Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Immunoassays and Enzymatic Assays
- 7.5.1 Overview
- 7.5.2 Immunoassays and Enzymatic Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Pulse Oximetry Screening Technology
- 7.6.1 Overview
- 7.6.2 Pulse Oximetry Screening Technology: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Other Technologies
- 7.7.1 Overview
- 7.7.2 Other Technologies: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

8.1 Overview
8.2 Europe Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
8.3 Dry Blood Spot Test
- 8.3.1 Overview
- 8.3.2 Dry Blood Spot Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Hearing Screen Test
- 8.4.1 Overview
- 8.4.2 Hearing Screen Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Critical Congenital Heart Diseases (CCHD) Test
- 8.5.1 Overview
- 8.5.2 Critical Congenital Heart Diseases (CCHD) Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Other Test Types
- 8.6.1 Overview
- 8.6.2 Other Test Types: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Europe Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals and Clinics
- 9.3.1 Overview
- 9.3.2 Hospitals and Clinics: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Newborn Screening Market - Country Analysis

10.1 Europe Newborn Screening Market
- 10.1.1 Europe Newborn Screening Market, by Country
  - 10.1.1.1 UK
    - 10.1.1.1.1 UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.1.2 UK: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.1.2.1 UK: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.1.2.2 UK: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.1.3 UK: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.1.1.4 UK: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.1.5 UK: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.2 Germany
    - 10.1.1.2.1 Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.2.2 Germany: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.2.2.1 Germany: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.2.2.2 Germany: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.2.3 Germany: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.1.2.4 Germany: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.2.5 Germany: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.3 France
    - 10.1.1.3.1 France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.3.2 France: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.3.2.1 France: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.3.2.2 France: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.3.3 France: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.1.3.4 France: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.3.5 France: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.4 Italy
    - 10.1.1.4.1 Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.4.2 Italy: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.4.2.1 Italy: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.4.2.2 Italy: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.4.3 Italy: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.1.4.4 Italy: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.4.5 Italy: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.5 Spain
    - 10.1.1.5.1 Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.5.2 Spain: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.5.2.1 Spain: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.5.2.2 Spain: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.5.3 Spain: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.1.5.4 Spain: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.5.5 Spain: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.6 Rest of Europe
    - 10.1.1.6.1 Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.6.2 Rest of Europe: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.6.2.1 Rest of Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.6.2.2 Rest of Europe: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 10.1.1.6.3 Rest of Europe: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.1.6.4 Rest of Europe: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.6.5 Rest of Europe: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

11. Europe Newborn Screening Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in Newborn Screening Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Zentech SA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 PerkinElmer Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Waters Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Masimo Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Natus Medical Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 MRC Holland BV
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms